VEEV241220C230000
- 4.30
- -0.30-6.52%
Veeva Systems Newsroom
Barclays Maintains Veeva Systems(VEEV.US) With Buy Rating, Maintains Target Price $260
Barclays Reaffirms Their Buy Rating on Veeva Systems (VEEV)
El 70% De Las Empresas De Tecnología Médica Utiliza Procesos Manuales Para Gestionar Contenidos
Report Reveals 70% of Medtechs Use Manual Processes for Managing Content and Claims
ACTO TRITT VEEVA AI PARTNER PROGRAM BEI, UM MESSAGING ZWISCHEN AUSSENDIENSTMITARBEITENDEN BEI PERSÖNLICHEN GESPRÄCHEN MIT GESUNDHEITSDIENSTLEISTERN ZU VERBESSERN
Veeva Announces AI in Vault CRM
Salesforce, Workday Are Top Picks at Scotiabank Amid Initiation of 13 Software-service Stocks
Veeva Announces New Digital Hazard Analysis and Critical Control Point (HACCP) Solution
ACTO JOINS VEEVA AI PARTNER PROGRAM TO STRENGTHEN FIELD TEAM MESSAGING DURING FACE-TO-FACE HCP INTERACTIONS
Analysts Offer Insights on Healthcare Companies: Lineage Therap (LCTX), Veeva Systems (VEEV) and Takeda Pharmaceutical Company (TAK)
Scotiabank Initiates Coverage On Veeva Systems With Sector Perform Rating, Announces Price Target of $235
Veeva Systems Analyst Ratings
Veeva Systems (VEEV) Rises But Trails Market: What Investors Should Know
Veeva to Release Fiscal 2025 Third Quarter Results on December 5, 2024
William Blair Maintains Veeva Systems(VEEV.US) With Buy Rating
Veeva Systems: Strong Market Position and Future Growth Potential Drive Buy Rating
Boehringer Ingelheim Commits to Veeva Vault CRM
Veeva Pulse Data Shows New Science Calls for More Connected Engagement
Reasons to Retain Veeva Systems Stock in Your Portfolio Now
Veeva Systems Insider Sold Shares Worth $270,252, According to a Recent SEC Filing